MVR-EX Series for neurodermatitis (Immvira)

N/A

Report date: 2025/04/29 10:04:41

Base Information

Drug NameMVR-EX Series for neurodermatitis (Immvira)
Drug Alias NameN/A
ClassificationBiologics > Exosomes
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurodermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImmvira Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmvira Co Ltd
Inactive CompaniesN/A
Active IndicationsNeurodermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A